SMAD3 and pulmonary fibrosis: MiR-29 can also directly act on the 3′-UTR of the target gene TGF-β1 [24], inhibit the transcription of TGF-β1 mRNA, and reduce pulmonary fibrosis through the inhibitory effect of the TGF-β1/Smad3 signaling pathway [5].